Profil bibliographique

Bruce Burnett

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

107Publications signalées

2441Citations signalées

2Affiliations récentes

Institutions déclarées

Eloxx Pharmaceuticals (United States)Arbor Pharmaceuticals (United States)

Domaines associés

Inflammatory mediators and NSAID effectsCOVID-19 Clinical Research StudiesAtrial Fibrillation Management and OutcomesPhytoestrogen effects and researchOsteoarthritis Treatment and Mechanisms

Publications récentes

2025 articleOpenAlex

63505 Vilobelimab Post-hoc Efficacy in Hidradenitis Suppurativa using the Modified-HiSCR with Data from the Phase 2b SHINE Study

Evangelos J. Giamarellos‐Bourboulis, Christopher J. Sayed, Camilla Chong, Hoda Tawfik et autres

0 citationsJournal of the American Academy of Dermatology

Accès ouvert 2025 articleOpenAlex

63560 Vilobelimab Safety in Pyoderma Gangrenosum Patients: A Phase 2a Explorative Dose-Finding Study

Afsáneh Alavi, Benjamin H. Kaffenberger, Hoda Tawfik, Camilla Chong et autres

0 citationsJournal of the American Academy of Dermatology

2025 articleOpenAlex

63490 Reduction in Draining Tunnels in Hidradenitis Suppurativa Patients Treated with Vilobelimab in a Randomized, Placebo-Controlled, Double-Blind Multicenter Phase 2b Study

Evangelos J. Giamarellos‐Bourboulis, Christopher J. Sayed, Jamie Weisman, Jacek C. Szepietowski et autres

0 citationsJournal of the American Academy of Dermatology

2025 articleOpenAlex

63550 Pharmacokinetic/Pharmacodynamic Analysis of Vilobelimab and Complement C3 and C5a in a Randomized, Controlled Multidose Phase 2a Study in Pyoderma Gangrenosum

Afsáneh Alavi, Hoda Tawfik, Camilla Chong, Joseph F. Grippo et autres

0 citationsJournal of the American Academy of Dermatology

2025 articleOpenAlex

63527 Vilobelimab Safety in Hidradenitis Suppurativa Patients in a Randomized, Placebo-Controlled, Double-Blind Multicenter Phase 2b study

Evangelos J. Giamarellos‐Bourboulis, Christopher J. Sayed, Jamie Weisman, Jacek C. Szepietowski et autres

0 citationsJournal of the American Academy of Dermatology

Accès ouvert 2025 articleOpenAlex

The cost-effectiveness of using vilobelimab with immunomodulators to treat severely ill mechanically ventilated patients with COVID-19: A subgroup analysis of the PANAMO study

Daniel C. Malone, Roger Seheult, Diana Brixner, Gary M. Oderda et autres

1 citationAmerican Journal of Health-System Pharmacy

2025 conference-abstractOpenAlex

Treatment of Viral-induced Acute Respiratory Distress Syndrome (ARDS) With Vilobelimab: A Focus on C5a Inhibition

Raymond M. Panas, Bruce Burnett, Cheng Tung Chong, Ruilin Guo et autres

1 citationAmerican Journal of Respiratory and Critical Care Medicine

Accès ouvert 2025 articleOpenAlex

Regional comparison of efficacy and safety for vilobelimab in critically ill, invasively mechanically ventilated COVID-19 patients

Endry H. T. Lim, Diederik van de Beek, Sanne de Bruin, Simon Rückinger et autres

0 citationsBMJ Open Respiratory Research

Accès ouvert 2025 articleOpenAlex

85. Improved Survival with Dual Immunomodulator Treatment of ARDS by blocking C5a and IL-6 Activity: Subanalysis from the PANAMO Study in Critically Ill COVID-19 Patients

Roy F. Chemaly, Alexander P. J. Vlaar, Endry H. T. Lim, Bruce Burnett et autres

2 citationsOpen Forum Infectious Diseases

2025 articleOpenAlex

645: VILOBELIMAB WITH BASELINE VASOPRESSOR USE IMPROVES MORTALITY IN CRITICALLY ILL COVID-19 PATIENTS

Bryan Kraft, Bruce Burnett, Raymond M. Panas, Camilla Chong et autres

0 citationsCritical Care Medicine

Accès ouvert 2024 articleOpenAlex

VILOBELIMAB IN COMBINATION WITH TOCILIZUMAB MAY SYNERGISTICALLY IMPROVE MORTALITY IN CRITICALLY ILL COVID-19 PATIENTS: A POST-HOC ANALYSIS OF THE PHASE III PANAMO STUDY

Christian E. Sandrock, A.P.J. Vlaar, Endry H. T. Lim, Bruce Burnett et autres

2 citationsCHEST Journal

Accès ouvert 2024 articleOpenAlex

Heterogeneity of treatment effect of vilobelimab in COVID-19: a secondary analysis of a randomised controlled trial

Rombout B. E. van Amstel, Marleen A. Slim, Endry H. T. Lim, Simon Rückinger et autres

7 citationsCritical Care

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.